PIPELINE WATCH: Three Approvals, Three Filings And Seven Phase III Studies

13 Jun 2016

• By John Davis

This week's Pipeline Watch, a snapshot of all the late-stage R&D and regulatory events in the pharma and biotech industries, is now available to view.

The table records clinical and regulatory developments using data from Biomedtracker. It lists all drugs for which an event was recorded from June 3 to June 9, 2016, divided by event type.

Events can include latest launches, approvals, withdrawals, suspensions, regulatory filings, CHMP recommendations, Phase III clinical trial initiations, development discontinuations, and...